Cantargia | PharmaShots

PharmaShots Weekly Snapshot (August 19 – 23, 2019)

August 26, 2019September 9, 2019Tuba Khan

OxThera’s Oxabact Receives EMA’s Positive Decision on Pediatric Investigational Plan to Treat Primary Hyperoxaluria Published: Aug 23, 2019 | Tags: OxThera, Oxabact, Receives, EMA, [Read More...]

Cantargia Extends its Licensing Agreement with BioWa for its POTELLIGENT Technology

Cantargia Extends Licensing Agreement with BioWa for its POTELLIGENT Technology

August 23, 2019August 23, 2019Tuba Khan

Shots: The extended agreement allows Cantargia to create and use additional CHO cell lines engineered utilizing BioWa’s POTELLIGENT technology and to develop and [Read More...]